Literature DB >> 12132663

Studies on intestinal absorption of sulpiride (1): carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2.

Kazuhiro Watanabe1, Tetsuya Sawano, Kazuaya Terada, Tetsuya Endo, Masakatsu Sakata, Juichi Sato.   

Abstract

We investigated whether the uptake of a specific antipsychotic agent, sulpiride, in Caco-2 cells is mediated by a carrier-mediated system. Caco-2 cell monolayers were cultured in plastic culture dishes and uptake and efflux studies were conducted. The determination of sulpiride was performed by HPLC. At 37 degrees C, sulpiride uptake in pH 6.0 was twice as much as in pH 7.4. At 4 degrees C, however, no significant difference was observed between pH 6.0 and 7.4. The uptake at 4 degrees C was markedly lower than that obtained at 37 degrees C. The subtraction of the uptake at 4 degrees C from the uptake at 37 degrees C indicated a saturable process, and the result of the Eadie-Hofstee plot analysis indicated that the uptake consists of two or more saturable components. The uptake was significantly inhibited by uncoupler, protonophore, amino acid modifying agent and proteinase. Sulpiride efflux was temperature-dependent and was significantly inhibited by uncoupler and amino acid modifying agent. These findings indicate that sulpiride uptake and efflux in Caco-2 cells are carrier-mediated. Furthermore, the uptake was significantly decreased by some substrates and inhibitors of peptide transporter, PEPT1, and organic cation transporters, OCTN1 and OCTN2, and was significantly increased by preloading with them. The uptake was also significantly increased by a typical substrate of P-glycoprotein. From these findings, we presumed that peptide transporter PEPT1 and organic cation transporters OCTN1 and OCTN2 are involved with this uptake. P-glycoprotein may also contribute to the efflux of sulpiride.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132663     DOI: 10.1248/bpb.25.885

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

Review 2.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

3.  Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2.

Authors:  Tsunehisa Takahashi; Tomomi Kaku; Takashi Sato; Kazuhiro Watanabe; Juichi Sato
Journal:  J Nat Med       Date:  2009-11-06       Impact factor: 2.343

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  An epichlorohydrin-crosslinked semi-interpenetrating GG-PEO network as a xerogel matrix for sustained release of sulpiride.

Authors:  Famida G Hoosain; Yahya E Choonara; Pradeep Kumar; Lomas K Tomar; Charu Tyagi; Lisa C du Toit; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

6.  Functionalized nanoporous silica for the removal of heavy metals from biological systems: adsorption and application.

Authors:  Wassana Yantasee; Ryan D Rutledge; Wilaiwan Chouyyok; Vichaya Sukwarotwat; Galya Orr; Cynthia L Warner; Marvin G Warner; Glen E Fryxell; Robert J Wiacek; Charles Timchalk; R Shane Addleman
Journal:  ACS Appl Mater Interfaces       Date:  2010-10       Impact factor: 9.229

7.  Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes.

Authors:  Tianxiang Kevin Han; Ruth S Everett; William R Proctor; Chee M Ng; Chester L Costales; Kim L R Brouwer; Dhiren R Thakker
Journal:  Mol Pharmacol       Date:  2013-05-16       Impact factor: 4.436

Review 8.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

9.  Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization.

Authors:  Hesham M Tawfeek; Yasser A Hassan; Mohammed F Aldawsari; Mohamed H Fayed
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-05

10.  Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers.

Authors:  Chuting Gong; Janvier Engelbert Agbokponto; Wen Yang; Ernest Simpemba; Xiaohong Zheng; Quanying Zhang; Li Ding
Journal:  Acta Pharm Sin B       Date:  2014-07-03       Impact factor: 11.413

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.